Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Severe Acute Malnutrition Results in Lower Lumefantrine Exposure in Children Treated With Artemether‐Lumefantrine for Uncomplicated MalariaPalang Chotsiri, Joel Tärning, Lubbe Wiesner et al.|Clinical Pharmacology & Therapeutics|2019Cited by 56
Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trialsHalimatou Diawara, Sara A. Healy, Agnes Mwakingwe-Omari et al.|The Lancet Infectious Diseases|2024Cited by 31
SARS-CoV-2 Seroassay Optimization and Performance in a Population with High Background Reactivity in MaliJohn Woodford, Patrick E. Duffy, Issaka Sagara et al.|SSRN Electronic Journal|2021Cited by 7
Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West AfricaJohn Woodford, Patrick E. Duffy, Issaka Sagara et al.|Frontiers in Immunology|2022Cited by 7